Related Experiment Videos

Inroads in transcatheter therapy for congenital heart disease

A M Mendelsohn¹, D Shim

¹Department of Pediatrics, Children's Hospital at Strong, University of Rochester Medical Center, New York 14642, USA.

The Journal of Pediatrics

|September 17, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

BLZ8 activates a plastidial peroxiredoxin and a ferredoxin to protect Chlamydomonas reinhardtii against oxidative stress.

Plant biology (Stuttgart, Germany)·2023

Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2).

The British journal of dermatology·2021

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials.

The Journal of dermatological treatment·2020

Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate-to-severe chronic plaque psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

ECM1 regulates tumor metastasis and CSC-like property through stabilization of β-catenin.

Oncogene·2015

See all related articles